Researchers at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) have designed influenza vaccine candidates based on group 2 influenza hemagglutinin (HA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback